CT评估血栓通透性与卒中病因的关联
本研究回顾性分析75例大脑中动脉M1段闭塞的急性缺血性卒中患者,通过非增强CT和CT血管造影测量血栓通透性(TP)。结果显示心源性栓塞患者的TP指标显著高于大动脉粥样硬化患者,且TP可独立预测心源性栓塞,血栓衰减增加值的曲线下面积为0.75。
要点
- 心源性栓塞患者血栓衰减增加值中位数2.79 HU,显著高于大动脉粥样硬化患者的-5.11 HU。
- 血栓衰减增加值每增加1单位,心源性栓塞的比值比为1.12(95%CI 1.04-1.22;P=0.004)。
- 以6.23 HU为截断值,识别心源性栓塞的 specificity 达100%。
核心结论
- 基线非增强CT/CT血管造影评估的血栓通透性有助于判断M1段闭塞患者的心源性栓塞病因。
研究设计与样本
- 回顾性分析前瞻性数据库中75例大脑中动脉M1段近端闭塞的急性缺血性卒中患者。
主要发现
- 心源性栓塞患者血栓衰减增加值中位数2.79(四分位距-3.54至8.85),大动脉粥样硬化患者为-5.11(-11.23至-1.47),P=0.001。
- 线性回归中仅卒中病因与血栓通透性显著相关。
- 多变量逻辑回归中仅血栓衰减增加值与心源性栓塞独立相关(OR 1.12,95%CI 1.04-1.22;P=0.004)。
- ROC分析显示血栓衰减增加值识别心源性栓塞的曲线下面积为0.75(95%CI 0.63-0.87)。
- 以6.23 HU为截断值,识别心源性栓塞的 specificity 为100%。
关键数值与推荐
- 血栓衰减增加值截断值6.23 HU时,心源性栓塞识别 specificity 为100%。
- 血栓衰减增加值OR 1.12(95%CI 1.04-1.22;P=0.004)。
- 曲线下面积0.75(95%CI 0.63-0.87)。
临床怎么用
- 基线非增强CT/CT血管造影测量血栓通透性可辅助判断心源性栓塞病因,指导二级预防。
局限性
- 回顾性分析,样本量75例,需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: A recent study proposed that thrombus perviousness (TP)-the degree to which contrast agents penetrate the thrombus in an occluded vessel measured on noncontrast computed tomography (NCCT) and CT angiography-may be associated with cardioembolic stroke cause with high specificity. Our aim was to investigate which clinical and laboratory parameters affect measures of TP and to validate its diagnostic accuracy in an independent cohort of patients with acute ischemic stroke. METHODS: Seventy-five patients from a prospectively maintained database with proximal occlusions of the middle cerebral artery (M1) were retrospectively analyzed. Thrombi were segmented on coregistered noncontrast computed tomography and CT angiography to determine the thrombus attenuation increase and void fraction (attenuation increase relative to contralateral side). RESULTS: TP measures were significantly higher in patients with cardioembolic stroke compared to patients with stroke attributed to large artery atherosclerosis (median thrombus attenuation increase [interquartile range], 2.79 [-3.54 to 8.85] versus -5.11 [-11.23 to -1.47]; P=0.001). In linear regression analysis for TP including age, time to scan, prior medication with antiplatelets or anticoagulants, and selected laboratory parameters, only stroke cause was significantly associated with TP. In multivariable binary logistic regression analysis for dichotomized stroke cause (ie, cardioembolic versus noncardioembolic stroke), only thrombus attenuation increase was independently associated with cardioembolic stroke (odds ratio of 1.12 [95% CI, 1.04-1.22]; P=0.004). Receiver operating characteristic analysis indicated that TP can identify cardioembolic stroke with an area under the curve of 0.75 (95% CI, 0.63-0.87) for thrombus attenuation increase. With a cutoff value of 6.23 Hounsfield units, cardioembolic strokes were identified with 100% specificity. Results for void fraction were similar. CONCLUSIONS: The assessment of TP on baseline noncontrast computed tomography/CT angiography in patients with M1 occlusion may aid in determining cardioembolic stroke cause and guide secondary prevention. Selected clinical and laboratory parameters other than stroke cause did not affect TP measures.
引用
- Kufner A, Erdur H, Endres M, et al. Association Between Thrombus Perviousness Assessed on Computed Tomography and Stroke Cause. Stroke. 2020. PMID: 32998650. doi:10.1161/STROKEAHA.120.031148
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。